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Abstract
Background Previous studies showed that exercise in cancer
patients is feasible and may reduce fatigue and improve
physical fitness and quality of life. However, many previous
studies had methodologicalweaknessesrelated totrial design,
sample size, comparison group, outcome measures, short
follow-up durations and programme content.
Purpose This paper aims to present the rationale and design
of the clinical research subprogramme of the Alpe d’HuZes
Cancer Rehabilitation (A-CaRe) programme.
Method A-CaRe Clinical Research includes four randomized
controlled trials in patients: (a) after chemotherapy, (b) during
chemotherapy, (c) after stem cell transplantation and (d)
during childhood cancer. These trials compare high-intensity
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DOI 10.1007/s12529-011-9158-5resistance and endurance exercise interventions with
usual care or a waiting list control group. In two studies,
a second intervention arm consisting of low-to-moderate
intensity exercise is included. All four A-CaRe trials use
similar methods.
Results Outcome measures are carefully chosen based on
the International Classification of Functioning Disability
and Health model. Measurements will be performed prior to
randomization (T0), after completion of the intervention
(T1) and at follow-up (T2). The primary outcome measures
are cardiorespiratory fitness, muscle strength and fatigue.
Secondary outcome measures include health-related quality
of life and psychosocial functioning. Furthermore, cost-
effectiveness and cost-utility analyses are performed from a
societal perspective.
Conclusion We hypothesize that exercise is more effective
at improving physical fitness and thereby reducing fatigue
and more cost-effective compared with usual care or a
waiting list control group. If so, the programmes will be
implemented in the Dutch clinical practice.
Keywords Exercise.Cancer.Rehabilitation.Physical
fitness.Muscle strength.Fatigue
Abbreviations
A-CaRe Alpe d’HuZes Cancer Rehabilitation
HRQoL Health-related quality of life
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Introduction
Recent advances in diagnosis and treatment of cancer
patients have led to improved survival rates, both for
children and adults. In The Netherlands, the current 5-year
survival rate across all cancers is approximately 62% for
female and 56% for male patients [1]. The survival rates of
childhood cancer have improved up to 75% [2, 3].
However, cancer treatment and survival are often associated
with prolonged psychosocial and physical complaints
[4, 5], including decreased muscle strength, reduced lean
body mass, reduced cardiorespiratory fitness, bone loss and
fatigue [6]. For example, approximately 70% of cancer
patients report fatigue complaints during chemotherapy
and/or radiotherapy [7–9], and even years after the end of
therapy, fatigue is still a major problem for at least 30% of
cancer survivors [9]. Feelings of fatigue may result in the
avoidance of activities to reduce the discomfort. However,
this may result in a self-perpetuating condition of dimin-
ished activity leading to reduced physical fitness, increased
muscle wasting and consequently to easy fatigue and
further physical inactivity [6, 9]. This has great impact on
the patient’s quality of life [7, 9]. This is also true for
survivors of childhood cancer [10]. Geenen et al. reported
that 75% of childhood cancer survivors had at least one
adverse health effect after a median follow-up of 17 years
[11]. Late health effects include adverse general and mental
health, activity limitations, functional impairments [2],
reduced physical fitness, increased fatigue and reduced
health-related quality of life (HRQoL) [12].
Several literature reviews summarized the available
scientific literature on the effects of exercise interventions
in adult cancer patients and survivors [4, 13–18]. These
studies suggest that cancer patients may benefit from
physical exercise both during and after treatment. The
suggested beneficial effects include improved physical
performance, self-reported functioning and psychological
and social well-being, as well as reduced fatigue and
increased quality of life [4, 13, 14, 16–18]. The majority of
the studies focused on patients with breast cancer, and
fewer studied colorectal, lung and prostate cancers [13, 15,
16]. A recent literature review of Liu et al. [15] reported
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conduct in haematological cancer patients and that results
on physical fitness, HRQoL and psychological well-being
were encouraging [15].
However, evidence of the beneficial effects of exercise in
cancer patients and survivors appeared to be limited due to
poor to moderate methodological quality of the studies.
Most studies were not randomized controlled trials (RCTs),
did not include appropriate control groups and/or were
based on small sample sizes. Furthermore, most exercise
interventions were sub-optimal regarding exercise physio-
logical aspects: Exercise programmes were relatively short
in duration (less than 12 weeks) and did not systematically
promote maintenance of physical activity among the
patients after the programme, and most studies included
only low-intensity aerobic exercise, such as walking or
cycling, rather than resistance exercise and high-intensity
exercise [13, 16, 19]. Since muscle atrophy is a common
problem in cancer patients [20], it seems advisable to
include resistance exercises as well. With appropriate
training stimuli, skeletal muscles can show great adaptability
even in case of severe muscle atrophy and fatigue [6].
In The Netherlands, a cancer rehabilitation programme
‘Recovery & Stability’ [21, 22] exists. This is a 12-week
supervised self-management exercise programme of low-to-
moderate intensity that combines endurance and resistance
exerciseswithgroupsportsactivities. The Recovery&Stability
programme showed improvements in physical fitness [21]a n d
quality of life [23], which sustained 9 months post-
intervention [23], but the study did not include a no-exercise
control group. Another cancer rehabilitation programme in
The Netherlands included high-intensity resistance and endur-
ance training after chemotherapy treatment and showed
improved physical performance and quality of life in cancer
patients compared with a historical control group [19]. These
effects persisted at 1 year follow-up [24].
In summary, previous studies showed that exercise-based
rehabilitation programmes of moderate or high intensity are
feasible and well tolerated by adult cancer patients and
survivors. However, RCTs including adequate sample sizes,
an appropriate control group and valid and reliable outcome
measures are limited. Furthermore, no studies have examined
the cost-effectiveness of any type of exercise programme in
cancer patients. Therefore, a cancer rehabilitation research
programme was proposed to and approved by the Dutch
Cancer Society, financed through this society by the so-called
Alpe d’HuZes foundation (www.opgevenisgeenoptie.nl), a
cancer research fund. This Alpe d’HuZes Cancer Reha-
bilitation (A-CaRe) programme includes a clinical re-
search subprogramme (A-CaRe Clinical Research) in
addition to subprogrammes aiming at patient empower-
ment and public relations. The primary objectives of A-
CaRe Clinical Research are to evaluate the effectiveness
of state-of-the-art exercise interventions with respect to
physical fitness and fatigue and secondarily HRQoL in
specific cancer patient and survivor groups and to
evaluate the cost-effectiveness of these interventions.
The present paper describes the design of the A-CaRe
Clinical Research programme.
Methods
A-CaRe Clinical Research includes four RCTs with follow-
up periods up to 1 year focusing on different subgroups: (a)
exercise after chemotherapy [25], (b) exercise during
chemotherapy [26], (c) exercise after stem cell transplanta-
tion [27] and (d) exercise during childhood cancer [28]
(Table 1).
The design of the A-CaRe trials is based on a conceptual
model, presented in Fig. 1. According to this model,
exercise improves physical fitness (cardiorespiratory fitness
and muscle strength), which improves fatigue and subse-
quently also physical function and HRQoL. Physical fitness
may also directly influence physical function and HRQoL.
In the A-CaRe trials, exercise interventions will be
compared with either a waiting list control group or usual
care. All four A-CaRe trials will use similar methods.
Study Population
Potentially eligible patients will be screened by the treating
physician for the presence of comorbid conditions that would
contraindicate participation in a physical exercise programme.
This includes patients who are wheelchair dependent or not
ableto performbasicphysicalactivitieslike walkingorcycling,
patients with contraindications for physical activity or exercise
(i.e. serious orthopaedic conditions that would hamper func-
tional recovery, serious cardiovascular or cardiopulmonary
risks), patients with serious psychiatric or cognitive problems
or severe emotional instability, patients suffering from malnu-
trition (evidenced by an unintended weight loss of more than
5% per monthormore than10% unintendedweight loss during
the previous 6 months), patients not being familiar with the
Dutch language, patients who are unable to follow exercise
instructions and patients participating in concurrent studies or
rehabilitation programmes containing physical activity or
exercise. Due to the focus on different patient populations,
each A-CaRe study has its own inclusion criteria. Table 2
presents the inclusion criteria for each RCT, as well as
additional trial-specific exclusion criteria.
Exercise Interventions
Table 1 presents the intervention and control arms of all
four A-CaRe trials. In general, the exercise interventions
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under supervision of a physical therapist twice a week, with
a duration of 60 min. Furthermore, all interventions include
a behavioural motivation component aimed at increasing
motivation and compliance to physical exercise. Patients
who completed treatment trained for 12 weeks. The
Recovery & Stability programme showed that an interven-
tion duration of 12 weeks was sufficient to achieve
beneficial effects on physical fitness and HRQoL [21].
Also De Backer et al. [19] showed the largest improve-
ments in physical fitness to occur in the first 12 weeks
training. However, patients after stem cell transplantation
who are treated more aggressively are at increased risk for
persistent complaints [29]; they are more likely to have
lower levels of physical fitness and higher levels of fatigue
and consequently may need more time to recover. There-
fore, for these patients, the intervention duration was
extended to 18 weeks.
In general, the high-intensity resistance programme will
consist of exercises targeting the large muscle groups of the
upper and lower extremities. Resistance exercises are
performed at 65% to 80% of the one repetition maximum
(1-RM), consisting of two sets of 10–15 repetitions. Every
4 weeks, the training progress is evaluated by means of an
indirect 1-RM test, and the training intensity is adjusted
accordingly.
The high-intensity endurance exercises are performed at
an intensity of 65% of the maximal workload of the steep
ramp test [30]. This corresponds to a score of 15 on the
Borg scale for ratings of perceived exertion [31]. Endurance
exercises are mainly performed on a cycle ergometer.
Additionally, other modes of endurance, such as rowing,
will be used depending on the patients’ preferences.
A behavioural motivation component is included to
improve compliance and stimulate physical activity outside
the exercise programme. Patients are encouraged to be
moderately physically active for at least 30 min, three times
per week in addition to the supervised programme. After
completion of the exercise intervention, patients are encour-
aged to be moderately physically active for at least 30 min
five times per week. Specific programme elements include
the provision of general and motivational information, both
Table 1 Intervention and control arms of the A-CaRe trials
1. Exercise after chemotherapy 2. Exercise during chemotherapy 3. Exercise after SCT 4. Exercise during
childhood cancer
Intervention duration 12 weeks Depending on duration of
chemotherapy
18 weeks 12 weeks
Intervention arm 1 High-intensity resistance
and endurance exercise
High-intensity resistance and
endurance exercise
High-intensity resistance
and endurance exercise
High-intensity resistance
and endurance exercise
Intervention arm 2 Low-to-moderate intensity
resistance and endurance
exercise
Low-to-moderate intensity
physical activity programme
––
Control arm Waiting list
a Usual care Usual care
b Usual care
SCT stem cell transplantation
aAfter 12 weeks, patients will start with the high-intensity resistance and endurance programme or the light-to-moderate intensity exercise
programme, depending on which programme they have been allocated to
bCurrently, 10–20% of patients after SCT participate in the Recovery & Stability programme, in most cases starting 6 months or longer after
transplantation
Fig. 1 Conceptual model of
the A-CaRe trials
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provision of specific advice about the desired intensity of
activity based on the Borg scale of rating perceived exertion.
In the studies evaluating the effectiveness of exercise
interventions after and during chemotherapy, a second
intervention arm is included consisting of low-to-moderate
intensity exercise. Detailed descriptions of the interventions
are presented elsewhere [25–28].
Assessments and Outcome Measures
All four A-CaRe trials use similar outcome measures,
which are carefully chosen based on the International
Classification of Functioning, Disability and Health (ICF)
of the World Health Organization [32]. The ICF provides a
useful framework for classifying the components of health
and consequences of a disease. According to the ICF, the
Table 2 Number of patients, participating hospitals and in- and exclusion criteria of the A-CaRe trials
Project # of patients Inclusion criteria Specific exclusion criteria
a Participating hospitals
1. Exercise after
chemotherapy
400 Histological confirmed breast,
colon, ovarian cancer or
lymphomas with no indication
of recurrent or progressive
disease
Maxima Medical Center Veldhoven/
Eindhoven, Catharina Hospital
Eindhoven, Elckerlieck Hospital
Helmond, Sint Anna Hospital, Geldrop,
VU University Medical Center
Amsterdam Aged between 18 and 70 years
Completion of (adjuvant)
chemotherapy with curative
intention and completion of
surgical treatment or
radiotherapy
2. Exercise during
chemotherapy
360 Histological confirmed primary
breast of primary colon cancer
who are scheduled to undergo
adjuvant chemotherapy
Amstelland Hospital, Antoni van
Leeuwenhoek Hospital, Bovenij
Hospital, Flevohospital, Medical
Center Alkmaar, Onze Lieve Vrouwe
Gasthuis, Rode Kruis Hospital
Beverwijk, Sint Lucas Andreas
Hospital, Spaarne Hospital Hoofddorp,
VU University Medical Center
Amsterdam, Waterland Hospital, Zaans
Medical Center
3. Exercise after
SCT
120 Haematological malignancies
undergoing high dose
chemotherapy and autologous
SCT
Multiple myeloma
undergoing a tandem
autologous–allogeneic SCT
Academic Medical Centre Amsterdam,
Antoni van Leeuwenhoek Hospital
Amsterdam, University Medical Center
Utrecht, Antonius Hospital Nieuwegein,
Haga Hospital The Hague Multiple myeloma in first line;
Hodgkin’s lymphoma or non-
Hodgkin’s lymphoma in first
relapse
Extensive osteolytic lesions
with risk of fracture
Aged between 18 and 65 years Severe infections
Sufficiently recovered from the
SCT and having peripheral
blood recovery
4. Exercise during
childhood cancer
100 Aged 8–18 years at the time of
intervention
Bone marrow transplantation Centre for Paediatric Oncology and
Haematology of VU University Medical
Center, Wilhelmina Children’s Hospital
University Medical Centre Utrecht,
Emma Children’s Hospital Academic
Medical Center Amsterdam
Diagnosed with any type of
childhood malignancy
Growth hormone treatment
Treated with chemo- and or
radiotherapy
No longer than 12 months off
treatment
SCT Stem cell transplantation
aAll four studies exclude patients who are wheelchair dependent or not able to perform basic activities like walking or cycling, patients with
contraindications for physical activity or exercise (i.e. serious orthopaedic conditions that would hamper functional recovery, serious
cardiovascular or cardiopulmonary risks), patients with serious psychiatric or cognitive problems or severe emotional instability, patients suffering
from malnutrition (evidenced by an unintended weight loss of more than 5% per month or more than 10% unintended weight loss during the
previous 6 months), patients not being familiar with the Dutch language, patients who are unable to follow exercise instructions and patients
participating in concurrent studies or rehabilitation programmes containing physical activity or exercise
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of cancer and its treatment), may concern body functions
and structures, as well as the performance of activities and
participation in life situations. Health states and the
development of disability are modified by contextual
factors including personal factors, such as sociodemo-
graphic data, and environmental factors, such as societal
attitudes and social support [32]. Furthermore, cancer and
its associated impairments, activity limitations and partic-
ipation restrictions may have consequences for HRQoL
(Fig. 2). In the ICF classification, the letters b, s, d and e
refer to the following components of the classification:
body functions, body structures, activities and participation
and environmental factors. The hierarchical code system of
the ICF consists of the abbreviation of the component and the
chapter number (e.g. b4 Functions of the cardiovascular,
haematological, immunological and respiratory systems),
followed by the second level (e.g. b455 Exercise tolerance
functions), the third level (e.g. b4551 Aerobic capacity)a n d
possibly a fourth level. The use of a lower-level (more
detailed level) category automatically implies that the higher-
level category is also applicable.
In oncology rehabilitation, the ICF framework is
suggested to be useful for selection of outcome measures
[33]. In A-CaRe Clinical Research, the outcome measures
are carefully selected to assess body functions as well as
activities and participation. Table 3 presents an overview of
the outcome measures and instrumentation that will be used
in A-CaRe Clinical Research, classified according to the
ICF. Primary outcome measures are cardiorespiratory
fitness, muscle strength and fatigue. Secondary outcome
measures include body composition, health-related quality
of life, physical activity, mood and sleep disturbances,
participation and autonomy, return to work and adverse
events.
All outcome measures are assessed at baseline, prior to
randomization (T0), at completion of the intervention (T1)
and at follow-up (T2). Follow-up measurements will be
performed 12 months after completion of the intervention.
In the RCT evaluating exercise during chemotherapy, T2
measurements take place 6 months after completion of the
intervention.
Primary Outcome Measures
Cardiorespiratory Fitness Cardiorespiratory fitness is
measured during a maximal exercise test on an electronically
braked cycle ergometer according to a ramp protocol [34], in
which the resistance gradually increases every 6 s aiming to
achieve the maximum within 8 to 12 min. For children and
adolescents, the Godfrey protocol is used [35]. In this
protocol, patients will begin pedalling at 0 W for 1 min, and
the workload increases by 10, 15 or 20 W each minute
depending on the patients’ height and clinical status [35]. All
patients are instructed to cycle with a pedal frequency
between 70 and 80 rpm and are encouraged to continue
exercising until exhaustion, or inability to maintain the pedal
frequency of 70 rpm. Expired gases are collected and
analysed breath by breath for O2,C O 2 and volume. The
average values of the last 30 s of exercise are used as
measures for peak oxygen uptake (peakVO2,i nl i t r e sp e r
minute), peak power output (peakW, in watt) and peak heart
rate (HR). Ventilatory threshold is determined by using the
oxygen equivalent method [36]. HR and respiratory exchange
ratio are used as objective criteria for peak exercise.
In the RCT evaluating exercise during chemotherapy,
peakVO2 cannot be determined directly, due to logistic
reasons. Therefore, an estimation of peakVO2 is made based
on the steep ramp test using a linear regression equation
[30]. This has been shown to be a reliable (ICC=0.996) and
valid method to estimate cardiorespiratory fitness in cancer
patients [30]. In the other three A-CaRe trials, the steep ramp
test is performed for adjustments of training intensities.
Muscle Strength Upper extremity muscle strength of adults
is measured using a JAMAR grip strength dynamometer.
Handgrip can be used to characterize general upper
extremity muscle strength [37–39] and can increase after
general upper extremity resistance training including
exercises that did not specifically involve handgrip strength
[40].
Lower extremity muscle strength of adults is tested by
the functional 30-s chair stand test. This test is a valid and
reliable measure of lower extremity strength in adults [41].
Patients are asked to stand upright from a chair with the
arms folded across the chest, then to sit down again and
repeat the action over a 30-s period. The number of times
that the patient rises to a full stand from the seated position
within 30 s is recorded [42–44].
For children and adolescents, upper and lower extremity
muscle strength is assessed using a handheld dynamometer.
Upper extremity muscles include grip, shoulder abductor
and wrist extensor strength. In the lower extremity, muscle
strength of the hip flexors and the knee and dorsal foot
extensors is measured. Three consecutive measurements are
performed using the ‘break method’, in which the examiner
gradually overcomes the muscle force and stops at the
moment the extremity gives way [45]. The highest value
will be registered.
Fatigue In adults, fatigue symptoms are assessed with the
Multidimensional Fatigue Inventory (MFI) [46]. The MFI
contains 20 items, organized into five scales: general
fatigue, physical fatigue, reduced activity, reduced motivation
and mental fatigue. The MFI subscales have good internal
consistency (average Cronbach’s alpha=0.84) [47].
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fatigue are assessed with the Fatigue Quality List (FQL) [48].
The FQL consists of 25 adjectives describing the fatigue
experience, organized into four subscales: frustrating,
exhausting, pleasant and frightening.
Secondary Outcome Measures
Fatigue in Children In children, fatigue is assessed by the
18-item Paediatric Quality of Life Inventory (PedsQL)
Multidimensional Fatigue Scale Acute Version, which is
designed to measure both the child’s and parents’ perception
of fatigue in paediatric patients [49]. It consists of three
subscales: general fatigue (six items), sleep rest fatigue
(six items) and cognitive fatigue. Both parent and child
reports were shown to be valid and reliable in childhood
cancer [49].
Mood Disturbances In adults, mood disturbances are
assessed with the 14-item Hospital Anxiety and Depression
Scale (HADS) [50, 51]. It yields a total score and separate
scale scores for anxiety and depression. Numerous studies
have applied the HADS to assess distress among cancer
patients [52–54]. Furthermore, the questionnaire has been
validated for use in the Dutch population [55].
The Children’s Depression Inventory is used to assess
symptoms of depression in children and adolescents with
cancer. Overall, this questionnaire has good internal
consistency and test–retest reliability and a positive
correlation with clinicians’ independent global depression
ratings [56].
Sleep Disturbances Sleep disturbances are assessed with the
Pittsburgh Sleep Quality Index (PSQI), an 18-item, self-rated
questionnaire assessing the quality of sleep and sleep
disturbances over a month [57]. A total score is derived as
well as seven subscales that include subjective sleep quality,
sleep latency, sleep duration, habitual sleep efficiency, sleep
disturbances, use of sleeping medication and daytime
dysfunction. Scores≥5 on the PSQI total scale, computed
as the sum of the seven subscales are associated with
clinically significant sleep disturbances [57].
Health-Related Quality of Life In adults, HRQoL is
assessed with the European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire
(EORTC QLQ-C30), a questionnaire specifically developed
to asses HRQoL in cancer patients [58]. It consists of 30
items, organized into five functional scales (physical, role,
emotional, cognitive, social), three symptom scales (pain,
fatigue and emesis) and an overall quality of life scale.
Additional single items address other symptoms commonly
experienced by cancer patients (e.g. insomnia, diarrhoea,
constipation etc.). Validity and reliability of the question-
naire have been established [58].
HRQoL in children and adolescents with cancer is
assessed by child self-report and parent-proxy report using
the PedsQL 4.0 Generic Core Scale and the PedsQL 3.0
Cancer module. The PedsQL 4.0 Generic Core Scale is a
23-item questionnaire encompassing physical, emotional,
social and school functioning domains. The PedsQL 3.0
Cancer module is a 27-item multidimensional cancer-
specific questionnaire that encompasses eight scales:
pain and hurt, nausea, procedural anxiety, treatment
anxiety, worry, cognitive problems, perceived physical
appearance and communication. Validity and reliability
of both child and parent reports of the PedsQL Generic
Core Scale and the Cancer Module has been shown
[49, 59].
Self-Perception and Behavioural Problems in Children and
Adolescents The Dutch version of the Self-Perception
profile for children (CBSK) and adolescents (CBSA) is
used to assess self-perception of scholastic competence,
social acceptance, physical appearance, behavioural con-
duct, global self-worth and close friendships. The ques-
tionnaire has good reliability and validity when used in
children 8 years and older [60, 61].
Internalizing and externalizing behavioural problems
are assessed using the Dutch translated and validated
Fig. 2 The International
Classification of Functioning,
Disability and Health (ICF)
model
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International Classification of Functioning, Disability and Health
Second level Third level Adults Children
Body functions
Chapter 1 Mental functions
b122 Global psychosocial functions CBCL, YRS
b126 Temperament and personality
functions
CBCL, YRS, CBSA/CBSK
(behavioural conduct)
b130 Energy drive and functions MFI, FQL PedsQL Multidimensional
Fatigue Scale Acute
version
b134 Sleep functions PSQI
b152 Emotional functions HADS CDI
b280 Sensations of pain EORTC QLQ-C30 symptom
scale
Chapter 4 Functions of the cardiovascular, haematological, immunological and respiratory systems
b410–b429 Cardiovascular
system functions
Heart rate Heart rate
b440–b449 Respiratory system
functions
Respiratory rate Respiratory rate
b455 Exercise tolerance
functions
b4551 Aerobic capacity PeakVO2 PeakVO2
b4552 Fatigability MFI
Chapter 5 Functions related to the digestive, metabolic and respiratory systems
b530 Weight maintenance BMI, skinfolds, hip and
waist circumference,
DEXA scan
BMI, DEXA scan
Chapter 7 Neuromusculoskeletal and movement-related functions
b730 Muscle power
function
b7304 Power of muscles of
all limbs
Upper extremity: handgrip
strength
Handheld dynamometer
for upper and lower
extremity Lower extremity: 30 s chair
stand test
Activities and participation
Chapter 4 Mobility
d410 Changing basic body
position
d4103 Sitting 30-s chair stand test
d4104 Standing 30-s chair stand test
d450 Walking PASE and accelerometer Accelerometer
d460 Moving around in
different locations
IPA (mobility and leisure)
d4600 Moving around within
the home
IPA (mobility and leisure)
d4601 Moving around within
buildings other than
home
IPA (mobility and leisure)
d4602 Moving around
outside the home
and other buildings
IPA (mobility and leisure)
d470 Using transportation d4700 Using human-powered
vehicles
PASE
Chapter 5 Self-care
d510 Washing oneself IPA (autonomy in self-care)
d530 Toileting IPA (autonomy in self-care)
d540 Dressing IPA (autonomy in self-care)
d550 Eating IPA (autonomy in self-care)
d560 Drinking IPA (autonomy in self-care)
150 Int.J. Behav. Med. (2012) 19:143–156Child Behaviour Checklist (CBCL) for children younger
than 11 years. The CBCL is a valid and reliable
instrument to assess the parents’ evaluation of internal-
izing and externalizing behaviour problems of children
[62] .F o rc h i l d r e na g e d1 1t o1 8y e a r so l d ,t h eY o u t hS e l f
Report is used.
Table 3 (continued)
International Classification of Functioning, Disability and Health
Second level Third level Adults Children
d570 Looking after one’s health IPA (autonomy in self-care)
Chapter 6 Domestic life
d620 Acquisition of goods and services
d6200 Shopping IPA (family role)
d640 Doing housework PASE, IPA (family role)
d6402 Cleaning living area IPA (family role)
d650 Caring for household objects IPA (family role)
Chapter 7 Interpersonal interactions and relationships
d750 Informal social relationships IPA (social relations) CBSA/CBSK
(close friendships)
d7502 Informal relationships
with co-inhabitants
IPA (social relations)
d760 Family relationships IPA (social relations)
d770
d7702 Sexual relationships IPA (social relations)
Chapter 8 Major life areas
d810–d839 Education Level of education Level of education, return
to school
CBSA/CBSK
(scholastic competence)
d815 Preschool education Level of education Level of education, return
to school
d820 School education Level of education Level of education, return
to school
d825 Vocational training Level of education Level of education, return
to school
d830 Higher education Level of education Level of education, return
to school
d840–d959 Work and Employment Type of employment,
return to work
d850 Remunerative employment Type of employment,
return to work
d850 Self-employment Type of employment,
return to work
d8501 Part-time employment
d8502 Full-time employment Type of employment,
return to work
d855 Non-remunerative employment Type of employment,
return to work
d870 Economic self-sufficiency IPA (family role) IPA (family role)
d880 Engagement in play Accelerometer
Chapter 9 Community, social and civic life
d920 Recreation and leisure IPA (mobility and leisure) IPA (mobility and leisure)
d9200 Play Accelerometer
d9201 Sports PASE and accelerometer Accelerometer
BMI body mass index, CBCL Child Behaviour Checklist, CBSA self-perception profile for adolescents, CBSK self-perception profile for children,
CDI Child’s Depression Inventory, DEXA dual energy X-ray, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer
Core Quality of Life Questionnaire C30, FQL Fatigue Quality list, HADS Hospital Anxiety and Depression Scale, IPA Impact on Participation and
Autonomy, MFI Multidimensional Fatigue Inventory, PSQI Pittsburgh Sleep Quality Index, VO2 oxygen uptake
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Autonomy (IPA) Questionnaire is used to assess functioning in
daily life of adults [63]. The IPA consists of 32 items assessing
perceived level of participation and autonomy, organized into
five domains: autonomy in the home, family role, autonomy
outside of the home, social relations and work and education.
An additional nine items assess perceived problems with
participation and autonomy. Internal consistency of the five
domain scores range from 0.81 to 0.91.
Physical Activity Objective levels of physical activity are
assessed using an accelerometer, a small and lightweight
device, which detects accelerations. Patients wear the
accelerometer on the right hip attached to a belt for 4–
7 days, including at least one weekend day. Although
accelerometers may underestimate some activities, such as
cycling and water activities, it is recognised as a reasonably
valid tool to objectively assess physical activity in adults
[64], as well as in children [65–67]. Accelerations are
converted into activity counts per minute, indicating the
level of physical activity.
Self-reported physical activity of adults is assessed using
the Physical Activity Scale for the Elderly (PASE). The
PASE is a brief, self-administered 7-day recall question-
naire, which consists of questions on leisure time, house-
hold and work-related physical activities [68]. The
frequency of activities is recorded as never, seldom (1 to
2 days/week), sometimes (3 to 4 days/week) or often (5–
7 days/week). The duration of activities is categorized as
less than 1 h, between 1 and 2 h, between 2 and 4 h or more
than 4 h. Paid or unpaid work, except for work that
involves mostly sitting activities such as office work, is
categorized as less than 1 h, between 1 and 4 h, between 5
and 8 h or more than 8 h [69]. The total activity score is
computed by multiplying the amount of time spent on each
activity (in hours per week) by the empirically derived item
weights and summing over all activities [68]. In healthy
adults, the PASE has shown to have high test–retest
reliability (r=0.84) [68] and reasonable validity as com-
pared with the doubly labelled water method (r=0.58) [70].
Results from our institution showed that the PASE had
good to excellent test-retest reliability in cancer patients and
good content validity [71].
Body Composition Body height and body weight are
assessed in all patients, and BMI is calculated. In addition,
fat mass, muscle mass and bone mineral density will be
assessed by whole body dual energy X-ray scans in adults,
children and adolescents, except for participants from the
exercise intervention during chemotherapy, due to logistic
reasons. In adults, also waist and hip circumferences and
thickness of four skinfolds (biceps, triceps, suprailiacal,
subscapular) are assessed.
Return to Work or School The following indicators of
return to work (RTW) or school (RTS) are measured using
self-reported calendars: time to partial and to full RTW or
RTS expressed in number of calendar days between the end
of treatment and the first day at work, time to full RTW or
RTS corrected for partial RTW or RTS and partial and full
RTW or RTS rate at T0, T1 and T2.
Covariates
Sociodemographic and Clinical Data Sociodemographic
data, including age, (parental) education, marital status,
living situation, work (or school) status, medication use and
lifestyle variables (e.g. smoking, physical activity prior to
diagnosis), are collected at baseline.
Clinical information is collected from the medical
records and includes date of diagnosis, stage and subtype of
disease, treatment history, type and dose of chemotherapy
and/or radiotherapy and adverse events during treatment.
During the follow-up period, data on disease status (response
to treatment, progression or relapse) and data on any
additional treatment are collected.
Moderating Variables At baseline, a series of questions is
asked to assess potential moderating variables including
pre-illness lifestyle (frequency, nature and intensity of
physical activity and exercise behaviour, or avoidance
thereof), current attitudes towards and beliefs about
exercise in general and exercise during or after treatment.
Information about behavioural, normative and control
beliefs about exercise, attitude towards exercise, subjective
norm, perceived behavioural control and intention is
collected using standardized questions as described by
Courneya et al. [72, 73]. These questions have previously
been used to evaluate exercise programmes in cancer
patients and survivors and are based on established health
behaviour theories, in particularly the Theory of Planned
Behaviour [74].
Adherence Compliance with the interventions is assessed by
self-report, and attendance and exercise logs filled in by
physicaltherapistsand psychologist(e.g.observedattendance
at and compliance with the exercise). Non-responders and
dropouts receive a short questionnaire to assess the reason for
non-participation or dropping out of the study.
Satisfaction with Intervention After completion of the
intervention programmes, patients are asked to complete a
brief questionnaire addressing the perceived efficacy of and
satisfaction with the programme, whether they would suggest
any changes to the programme and if they would recommend
it to other patients undergoing similar treatments.
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grammes in adult patients are actively monitored during the
study with a special emphasis on increased fatigue, reported
by the patients, physiotherapists, sports physicians or
trainers and checked in the medical records. In addition,
in patients from the RCTs that evaluate training after
chemotherapy and after stem cell transplantation, neurotoxicity
is evaluated using the Chemotherapy-Induced Peripheral
Neuropathy (CIPN20) questionnaire [75]. This is an EORTC
quality of life questionnaire that is specifically developed to
assess chemotherapy-induced peripheral neuropathy.
Costs from a Societal Perspective
Besides the costs of the exercise programmes, data on
health care costs, patient and family costs and costs of
production losses are collected using monthly cost diaries
measured on a three-monthly basis during the entire follow-
up period. Health care costs include the costs of oncological
care, general practice care and physiotherapy, additional
visits to other health care providers, prescription of
medication, professional home care and hospitalization.
Patient and family costs include out-of-pocket expenses
such as travel expenses and costs for paid and unpaid help.
Costs related to production losses include work absenteeism
for patients (or parents) with paid jobs and days of inactivity
for patients (or parents) without a paid job.
Utilities are measured using the EuroQol (EQ5D) [76].
The EQ5D is a health-related quality of life measure that
provides a single index of an individual’s quality of life. It
consists of five dimensions: mobility, self-care, usual
activities, pain/discomfort and anxiety and depression. Each
dimension is rated as ’no problem’, ‘some problem’ or
‘extreme problem’, resulting in 243 possible health states [76].
Dutch tariffs will be used to value these health states [77].
Statistical Analyses
Data will be analysed on an intention-to-treat basis, in which
allpatientswillbeincludedinthegrouptheywereallocatedto
by randomization. In addition, a per-protocol analysis will be
performed in which we only include participants who
completed the intervention they were allocated to according
to the protocol. Completing the intervention is defined as
having attained 75% of all training sessions.
Multi-level longitudinal regression analysis will be
conducted to assess between-group differences in each
outcome measure. The follow-up value will be defined as
the dependent variable and the following levels will be
used: (1) time of follow-up measurement (values
corresponding with performance at T1 and T2), (2) training
centre and (3) individual. Regression coefficients indicate
differences between intervention and control groups. Regres-
sion models will be adjusted for the baseline values of the
respective outcome measures. Missing values will be avoided
as much as possible by asking participants to comply to the
post-test and follow-up measurement even after they drop out
from the exercise programme. Missing values will be
accounted for in the mixed linear regression modelling.
Costs are valued using the guidelines published in the
updated handbook for economic evaluation in The Nether-
lands, issued by the Dutch Health Care Insurance Board
[78]. Both incremental cost-effectiveness and cost–utility
analyses are performed. The cost-effectiveness ratio is
calculated by dividing the difference between the mean
total costs of the exercise and control groups by the
difference in mean effects of the group(s) [79]. The primary
clinical effect measures of the trials will be included in the
cost-effectiveness analyses. The cost–utility ratio expresses
the additional costs of the intervention compared with the
control group per quality adjusted life years. Cost-effectiveness
and cost–utilities ratios are estimated using bootstrapping
techniques and uncertainty of these ratios graphically presented
on cost-effectiveness and cost–utility planes, and acceptability
curves [79, 80]. Sensitivity analyses on the most important
cost drivers are performed in order to assess the robustness
of results.
Discussion
This paper presents the design and methods of four
randomized controlled trials on exercise-based rehabilitation
programmes included in the A-CaRe Clinical Research
programme. These studies are designed to evaluate the
effectiveness and cost-effectiveness of exercise-based reha-
bilitation programmes in different cancer patient and survivor
groups. The outcome measures of the studies are carefully
chosen based on the ICF, and the instrumentation is
standardized, valid and reliable. It is hypothesized that
exercise-based rehabilitation programmes are more effective
at improving cardiorespiratory fitness and muscle strength,
and thereby reducing fatigue, and more cost-effective com-
pared with usual care or a waiting list control group. In
addition, we compare the results of high-intensity training to
low-to-moderate intensity training.
Unlikecardiovasculardiseasesorother chronic conditions,
exercise-based rehabilitation programmes are currently not
part of standard health care for cancer patients and survivors
in The Netherlands. Before being able to implement cancer
rehabilitation programmes on a large scale, the efficacy of
such programmes need to be established. This is the main aim
oftheA-CaReprogramme.Inadditiontotheevaluationofthe
effectiveness and cost-effectiveness of the exercise interven-
tions, we need to gain insight in how (mediators), for whom
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tions are effective. Insight in mediators and moderators of
exercise interventions is essential to be able to tailor cancer
rehabilitation programmes to the needs, preferences and
characteristics of individual cancer patients. With the large
databaseresultingfromthefourA-CaRetrials,wewillbeable
toexploreseveralmediatorsandmoderatorsofexercise-based
cancer rehabilitation programmes.
In conclusion, the four A-CaRe trials evaluate the effective-
ness and the cost-effectiveness of various exercise-based
rehabilitation programmes in cancer patients and survivors, in
comparison with usual care or no treatment.
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